Delivery Order SPE2DB20D3103-SPE2DB25FP7T7
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,289.80 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 3, 2025, for the supply of Concerta ER 27 mg tablets (100 count) with a ceiling value of $8,652.19. This is a firm fixed price, non-set-aside competitively awarded delivery order with an ultimate completion date of June 4, 2025. The order will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 4, 2025, for the supply of Concerta ER 36 mg tablets (100 count units) with a ceiling value of $4,310.92. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 5, 2025. The award fulfills the federal government's pharmaceutical...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,458.88 by the Defense Logistics Agency for the supply of Concerta ER 18 mg tablets (100-count packages). This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by June 20, 2025. The products will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This award represents a single transaction within AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $5,679.26. The award is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside contract. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $6,600.47 for Concerta ER 18 mg tablets (100-count packages). This competitive, firm fixed-price contract was awarded on June 18, 2025, with an ultimate completion date of June 20, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $26,058.71 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count units) under a firm fixed price arrangement. The contract, which commenced on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-competitive delivery against an existing Indefinite Delivery Contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $24,486.26 for Concerta ER Tablets 36mg on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price, non-set-aside contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $18,011.60 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count bottles) under a firm fixed-price contract. This non-set-aside award was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $18,938.90 to AmerisourceBergen Drug Corp for the supply of Concerta ER 54 mg tablets (100 count) under a firm fixed price contract. This non-competitive delivery order was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7T7Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $19,079.33 by the Defense Logistics Agency (DLA) for the supply of Concerta ER 27 mg tablets (100-count units). This competitively awarded, firm fixed-price contract is non-set-aside and was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order represents a child contract under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA, operating under the Department of Defense, leverages this prime vendor arrangement to efficiently supply pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. The firm fixed-price delivery order model enables flexible procurement of critical medications while maintaining cost certainty for the government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 8/7/25 |